U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    GIGYF2 GRB10 interacting GYF protein 2 [ Homo sapiens (human) ]

    Gene ID: 26058, updated on 10-Dec-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    RNA-binding protein GIGYF2 orchestrates hepatic insulin resistance through STAU1/PTEN-mediated disruption of the PI3K/AKT signaling cascade.

    RNA-binding protein GIGYF2 orchestrates hepatic insulin resistance through STAU1/PTEN-mediated disruption of the PI3K/AKT signaling cascade.
    Lv Z, Ren Y, Li Y, Niu F, Li Z, Li M, Li X, Li Q, Huang D, Yu Y, Xiong Y, Qian L., Free PMC Article

    09/24/2024
    Translational repression of NMD targets by GIGYF2 and EIF4E2.

    Translational repression of NMD targets by GIGYF2 and EIF4E2.
    Zinshteyn B, Sinha NK, Enam SU, Koleske B, Green R., Free PMC Article

    12/4/2021
    Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

    Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.
    Saini P, Rudakou U, Yu E, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Fahn S, Waters C, Monchi O, Dauvilliers Y, Dupré N, Greenbaum L, Hassin-Baer S, Espay AJ, Rouleau GA, Alcalay RN, Fon EA, Postuma RB, Gan-Or Z., Free PMC Article

    11/13/2021
    4EHP and GIGYF1/2 Mediate Translation-Coupled Messenger RNA Decay.

    4EHP and GIGYF1/2 Mediate Translation-Coupled Messenger RNA Decay.
    Weber R, Chung MY, Keskeny C, Zinnall U, Landthaler M, Valkov E, Izaurralde E, Igreja C., Free PMC Article

    09/25/2021
    GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RNAs to Assist Ribosome-Associated Quality Control.

    GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RNAs to Assist Ribosome-Associated Quality Control.
    Hickey KL, Dickson K, Cogan JZ, Replogle JM, Schoof M, D'Orazio KN, Sinha NK, Hussmann JA, Jost M, Frost A, Green R, Weissman JS, Kostova KK., Free PMC Article

    10/3/2020
    GIGYF2 has two distinct mechanisms of repression: one depends on 4EHP binding and mainly affects translation; the other is 4EHP-independent and involves the CCR4/NOT complex and its deadenylation activity.

    4EHP-independent repression of endogenous mRNAs by the RNA-binding protein GIGYF2.
    Amaya Ramirez CC, Hubbe P, Mandel N, Béthune J., Free PMC Article

    07/27/2019
    genetic analyses of indel loci in ACE, DJ-1, and GIGYF2 genes, was performed to explore the potential contribution of insertion (I)/deletion (D) polymorphisms (indels) to the risk of PD in a Chinese population.

    Genetic analysis of indel markers in three loci associated with Parkinson's disease.
    Huo Z, Luo X, Zhan X, Chu Q, Xu Q, Yao J, Pang H., Free PMC Article

    10/21/2017
    Full-length GIGYF2 coimmunoprecipitates with AGO2 in human cells, and upon tethering to a reporter mRNA, GIGYF2 exhibits strong, dose-dependent silencing activity, involving both mRNA destabilization and translational repression.

    Post-transcriptional gene silencing activity of human GIGYF2.
    Kryszke MH, Adjeriou B, Liang F, Chen H, Dautry F.

    05/13/2017
    required, this finding may shed light on the GIGYF2-associated mechanisms that lead to PD and suggests insulin dysregulation as a disease-specific mechanism for both PD and cognitive dysfunction.

    GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment.
    Ruiz-Martinez J, Krebs CE, Makarov V, Gorostidi A, Martí-Massó JF, Paisán-Ruiz C., Free PMC Article

    10/1/2016
    Results suggest that the N56S and N457T of GIGYF2 are risk factors for Parkinson's disease in Caucasians, but not in Asians

    The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.
    Zhang Y, Sun QY, Yu RH, Guo JF, Tang BS, Yan XX.

    08/13/2016
    GIGYF2 and the zinc finger protein 598 (ZNF598) are identified as components of the 4EHP complex.

    A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development.
    Morita M, Ler LW, Fabian MR, Siddiqui N, Mullin M, Henderson VC, Alain T, Fonseca BD, Karashchuk G, Bennett CF, Kabuta T, Higashi S, Larsson O, Topisirovic I, Smith RJ, Gingras AC, Sonenberg N., Free PMC Article

    11/3/2012
    Our result indicated that SCNA, LRRK2, UCHL1, HtrA2 and GIGYF2 genes' mutations might not be a main reason for Chinese Autosomal dorminant Parkinson's disease

    Mutation analysis of LRRK2, SCNA, UCHL1, HtrA2 and GIGYF2 genes in Chinese patients with autosomal dorminant Parkinson's disease.
    Tian JY, Guo JF, Wang L, Sun QY, Yao LY, Luo LZ, Shi CH, Hu YC, Yan XX, Tang BS.

    09/8/2012
    within the Chinese population, the c.297T>C p.Ala99Ala polymorphism of the GIGYF2 gene may be associated with an increased risk of developing Parkinson disease.

    Follow-up study of variants of the GIGYF2 gene in Chinese patients with Parkinson’s disease.
    Wang L, Guo JF, Zhang WW, Xu Q, Zuo X, Shi CH, Luo LZ, Liu J, Hu L, Hu YC, Yan XX, Tang BS.

    07/21/2012
    These data, together with those recently reported by other groups, suggest that GIGYF2 is unlikely to be the PARK11 gene.

    Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene.
    Guella I, Pistocchi A, Asselta R, Rimoldi V, Ghilardi A, Sironi F, Trotta L, Primignani P, Zini M, Zecchinelli A, Coviello D, Pezzoli G, Del Giacco L, Duga S, Goldwurm S.

    01/21/2012
    No clearly pathogenic mutations are identified in GIGYF2 and ATP13A2 in Brazilian patients with early-onset Parkinson's disease.

    Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
    Dos Santos AV, Pestana CP, Diniz KR, Campos M, Abdalla-Carvalho CB, de Rosso AL, Pereira JS, Nicaretta DH, de Carvalho WL, Dos Santos JM, Santos-Rebouças CB, Pimentel MM.

    08/20/2011
    The results of this study did not support a role for GIGYF2 in the genetic etiology of Belgian Parkinson disease.

    GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population.
    Meeus B, Nuytemans K, Crosiers D, Engelborghs S, Pals P, Pickut B, Peeters K, Mattheijssens M, Corsmit E, Cras P, De Deyn PP, Theuns J, Van Broeckhoven C.

    04/2/2011
    GIGYF2 is unlikely to play a major role in PD in Japanese patients, similar to other populations.

    No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients.
    Li L, Funayama M, Tomiyama H, Li Y, Yoshino H, Sasaki R, Kokubo Y, Kuzuhara S, Mizuno Y, Hattori N.

    10/4/2010
    our findings suggest that GIGYF2 variants are not a frequent cause of Parkinson's disease in the Spanish population, since we found no clearly segregating GIGYF2 variants

    Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population.
    Samaranch L, Lorenzo E, Pastor MA, Riverol M, Luquin MR, Rodríguez-Oroz MC, Obeso JA, Pastor P.

    08/23/2010
    GIGYF2 variants are not associated with Parkinson's disease in the mainland Chinese Population.

    The GIGYF2 variants are not associated with Parkinson's disease in the mainland Chinese population.
    Cao L, Zhang T, Zheng L, Wang Y, Wang G, Zhang J, Fei QZ, Cui PJ, Wang XJ, Ma JF, Xiao Q, Chen SD.

    07/19/2010
    The results of this study do not support a major role of GIGYF2 in parkinson disease.

    Follow-up study of the GIGYF2 gene in French families with Parkinson's disease.
    Lesage S, Condroyer C, Lohman E, Troiano A, Tison F, Viallet F, Damier P, Tranchant C, Vidhaillet M, Ouvrard-Hernandez AM, Dürr A, Brice A, French Parkinson's Disease Genetics Study Group (FPDGSG).

    07/19/2010
    Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)

    Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article

    06/30/2010
    We identified nine novel variants in GIGYF2 gene, which might be associated with PD in the Chinese population.

    Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population.
    Wang L, Guo JF, Zhang WW, Xu Q, Zuo X, Shi CH, Luo LZ, Liu J, Hu L, Hu YC, She L, Jiang H, Yan XX, Xia K, Pan Q, Tang BS.

    04/12/2010
    GIGYF2 mutations are not a frequent cause of Parkinson's disease

    GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.
    Di Fonzo A, Fabrizio E, Thomas A, Fincati E, Marconi R, Tinazzi M, Breedveld GJ, Simons EJ, Chien HF, Ferreira JJ, Horstink MW, Abbruzzese G, Borroni B, Cossu G, Dalla Libera A, Fabbrini G, Guidi M, De Mari M, Lopiano L, Martignoni E, Marini P, Onofrj M, Padovani A, Stocchi F, Toni V, Sampaio C, Barbosa ER, Meco G, Italian Parkinson Genetics Network, Oostra BA, Bonifati V.

    01/21/2010
    The GIGYF2 Asn56Ser mutation is rare in Chinese PD patients.

    GIGYF2 Asn56Ser mutation is rare in Chinese Parkinson's disease patients.
    Zhang Y, Zheng L, Zhang T, Wang Y, Xiao Q, Fei QZ, Cui PJ, Cao L, Chen SD.

    01/21/2010
    This letter suggested that GIGYF2 is neither responsible for PARK11 nor a gene implicated in Parkinson disease.

    GIGYF2 variants are not associated with Parkinson's disease in Italy.
    Bonetti M, Ferraris A, Petracca M, Bentivoglio AR, Dallapiccola B, Valente EM.

    01/21/2010
    firstprevious page of 2 nextlast